Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial
At a glance
Conditions
NCT06243068
Where you'd take part
This study runs at 25 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Clinical Renal Associates
Exton, Pennsylvaniano site contact published
Medstar Washington Hospital Center
Washington D.C., District of Columbiano site contact published
North Texas Kidney Disease Associates
Lewisville, Texasno site contact published
North Texas Kidney Disease Associates
North Richland Hills, Texasno site contact published
North Texas Kidney Disease Associates
Plano, Texasno site contact published
Penn Presbyterian Medical Center
Philadelphia, Pennsylvaniano site contact published
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvaniano site contact published
Renal Disease Research Institute
Dallas, Texasno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Proportion of patients choosing Alternative Treatment Plans (ATP)Month 4 after enrollment.
Numerator: number of patients choosing an alternative treatment plan. Denominator: enrolled patients with decision-making capacity.